Tag

Alachua

Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua’s Progress District

Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company. The site will be located adjacent to Lacerta Therapeutics' current location in Alachua, Florida, in Copeland Park, which Lacerta has occupied since 2020.

CITI Program and Biotility at UF Announce Partnership

The Collaborative Institutional Training Initiative (CITI Program), the leader in online research, ethics, and compliance training, and Biotility at the University of Florida announced an exclusive licensing agreement to offer select Biotility’s biotech training courses on CITI Program’s learning platform.

University of Florida Innovators Honored at 4th Annual Standing InnOvation Event

On a sunny and fresh fall afternoon, UF Innovate | Tech Licensing hosted its annual event to recognize top innovations stemming out of the University of Florida. More than 150 innovators and entrepreneurs attended the in-person event, and around 40 joined the livestream to celebrate their achievements in fiscal year 2021.

AGTC Breaks Ground on New Biotech Lab in Alachua

Applied Genetic Technologies Corporation will build a new 21,000 square foot laboratory facility in Alachua. The facility will include control labs and a manufacturing suite and will add 50 jobs.

UF Innovate Names New Director of Incubation Services

UF Innovate is pleased to welcome Karl R. LaPan as the incoming director of incubation services. He will join the team May 3 and work alongside current Director Mark S. Long, who will retire this summer. LaPan comes to the position with more than 20 years of experience in business incubation.

Resilience Acquires Biologics Manufacturing Company Ology Bioservices

Resilience, a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., a privately held company that also specializes in biologic drug substance manufacturing from early-stage through commercial products.